- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Noninvasive Transdermal Drug Delivery Technology for Biopharmaceuticals as an Alternative to Injection
-
- Goto Masahiro
- Department of Applied Chemistry, Faculty of Engineering, Kyushu University Advanced Transdermal Drug Delivery System Center, Kyushu University
-
- Tanaka Keisuke
- Department of Applied Chemistry, Faculty of Engineering, Kyushu University
-
- Toyofuku Kiyohiro
- Department of Applied Chemistry, Faculty of Engineering, Kyushu University
Bibliographic Information
- Other Title
-
- 注射に代わるバイオ医薬品の非侵襲的経皮薬物送達技術
- –Breakthroughs by Membranous Approaches–
- –膜学的アプローチによるブレークスルー–
Search this article
Description
The share of biopharmaceuticals is expected to further increase in the future. Biopharmaceuticals, which consist of peptides and proteins, are anticipated to exhibit greater specificity to target molecules within the body compared to small molecule drugs. However, most biopharmaceuticals are administered by injection because they are broken down by enzymes when taken orally. We have been exploring the development of transdermal formulations (e.g., patches or ointments) as an alternative to injectable biopharmaceuticals. In this review, we introduce the transdermal delivery of insulin, a representative peptide drug, and present a transdermal vaccine for malaria as an alternative to injection. Finally, we discuss cutting–edge research on transdermal formulations for the latest nucleic acid drugs.
Journal
-
- MEMBRANE
-
MEMBRANE 49 (6), 293-299, 2024
THE MEMBRANE SOCIETY OF JAPAN
- Tweet
Details 詳細情報について
-
- CRID
- 1390583934062103040
-
- ISSN
- 18846440
- 03851036
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
-
- Abstract License Flag
- Disallowed